Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $31.36 in the prior trading day, Ideaya Biosciences Inc (NASDAQ: IDYA) closed at $30.48, down -2.81%. In other words, the price has decreased by -$2.81 from its previous closing price. On the day, 1.05 million shares were traded. IDYA stock price reached its highest trading level at $31.3 during the session, while it also had its lowest trading level at $29.77.
Ratios:
Our goal is to gain a better understanding of IDYA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.39 and its Current Ratio is at 12.39. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Guggenheim on September 18, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
On September 04, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $41.
On September 04, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $40.Barclays initiated its Overweight rating on September 04, 2025, with a $40 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 2671379456 and an Enterprise Value of 2105364992. For the stock, the TTM Price-to-Sale (P/S) ratio is 381.63 while its Price-to-Book (P/B) ratio in mrq is 2.78. Its current Enterprise Value per Revenue stands at 300.766 whereas that against EBITDA is -5.515.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.05, which has changed by 0.031239748 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $33.64, while it has fallen to a 52-week low of $13.45. The 50-Day Moving Average of the stock is 12.00%, while the 200-Day Moving Average is calculated to be 36.21%.
Shares Statistics:
The stock has traded on average 1.22M shares per day over the past 3-months and 1138040 shares per day over the last 10 days, according to various share statistics. A total of 87.64M shares are outstanding, with a floating share count of 80.64M. Insiders hold about 8.00% of the company’s shares, while institutions hold 104.23% stake in the company. Shares short for IDYA as of 1760486400 were 8481677 with a Short Ratio of 6.97, compared to 1757894400 on 9459498. Therefore, it implies a Short% of Shares Outstanding of 8481677 and a Short% of Float of 11.42.
Earnings Estimates
Currently, 15.0 analysts are dedicated to thoroughly evaluating and rating the performance of Ideaya Biosciences Inc (IDYA) in the stock market.The consensus estimate for the next quarter is -$0.87, with high estimates of -$0.6 and low estimates of -$1.05.
Analysts are recommending an EPS of between -$0.98 and -$3.6 for the fiscal current year, implying an average EPS of -$2.96. EPS for the following year is -$3.41, with 16.0 analysts recommending between -$2.5 and -$4.17.
